close-icon

MHQ: Clinical IntelligencePowered by SurvivorNet

  • health-panel

    Medical History

  • clinical-trial

    Clinical Trials

    ?
Prefer to talk instead of typing?
close-icon

Answers offered are informational and do not constitute medical advice. Learn more

close-icon
Medical History

Review your patient’s information.

What is your gender?

What is your age?

close-icon
Clinical Trials

clinical-icon

filter

Clear List

Ask me anything about your health...

I’m listening

thinking

responding

close-icon close-icon
close-icon
close-icon
close-icon
left-icon Back to Results

Dr. Alexey Danilov

location-icon

Los Angeles, CA

LOCATION OF PRACTICE
City Of Hope
MEDICAL Specialty:

Chronic Lymphocytic Leukemia (cll), Hematology & Hematopoietic Cell Transplantation, Lymphoma, Mantle Cell Lymphoma, Non-hodgkin Lymphoma



ABOUT

Dr. Alexey Danilov is a board-certified clinician and talented researcher. Dr. Danilov is an internationally recognized physician, clinical trialist, and translational investigator with expertise in chronic lymphocytic leukemia, mantle cell lymphoma, and non-Hodgkin lymphoma.

Dr. Alexey Danilov profile image

Published Articles

Early intervention in CLL: not a Chekhov's gun.- 2026 Aug 27
MRD-negativity by PBMCs and ctDNA confirms deep and durable responses following epcoritamab monotherapy in R/R FL.- 2026 Jul 10
CEACAM1 expression by immunohistochemistry in B-cell lymphomas and plasma cell myeloma.- 2026 Jun 4
Prognostic factors and survival outcomes in relapsed/refractory aggressive B-cell lymphomas treated with epcoritamab.- 2026 Aug 25
Cyclin-Dependent Kinase 5 Contributes to Bruton's Tyrosine Kinase Inhibitor Resistance via the IRE1α/XBP1 Axis in Mantle Cell Lymphoma.- 2026 May 8
Cyclin-Dependent Kinase-9 and Oxidative Phosphorylation Inhibition Overcomes Ibrutinib Resistance in Mantle Cell Lymphoma.- 2026 May 1
Mantle cell lymphoma outcomes following sequential first-line bendamustine-rituximab and second-line Bruton's tyrosine kinase inhibitor therapy.- 2026 Apr 25
Clinical strategies for lymphoma management: Recommendations from the Bridging the Gaps in Leukemia, Lymphoma, and Multiple Myeloma Consensus Conference 2025.- 2026 Apr 15
Prognosis and treatment of plasmablastic lymphoma in the United States: a multicenter retrospective study.- 2026 Mar 23
Real-world outcomes and toxicities of CAR-T in relapsed/refractory follicular lymphoma: a multicenter cohort study.- 2026 Jun 9

Clinical Trials

Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
Clinical Study of Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
Effect of Sorafenib or Regorafenib on P63 Expression and Keratinocyte Differentiation in Human Skin
Zanubrutinib in Combination With Odronextamab for the Treatment of Patients With Richter's Transformation
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Nemtabrutinib With Rituximab for the Treatment of Patients With Mantle Cell Lymphoma
A Study of the Effect of Vinca Alkaloids on c-Jun N-terminal Kinase (JNK) Phosphorylation in Patients With Chronic Lymphocytic Leukemia (CLL)
Copanlisib and Venetoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
Venetoclax and Obinutuzumab Followed by Epcoritamab for the Treatment of Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma, LonGEVity Trial
Copanlisib and Nivolumab in Treating Patients With Richter's Transformation or Transformed Indolent Non-Hodgkin Lymphoma

My Patient Resources

Other Specialists treating Chronic Lymphocytic Leukemia (CLL), Hematology & Hematopoietic Cell Transplantation, Lymphoma, Mantle Cell Lymphoma, Non-Hodgkin Lymphoma in Los Angeles, CA

See All Doctors

Dr. Gary Schiller

Specialty: acute and chronic leukemias, multiple myeloma, and other hematologic malignancies, as well as in stem cell and bone marrow transplantation

My Resources
location-icon

UCLA Health

My Resources

Dr. Kevin Kelly

Specialty:

My Resources
location-icon

Keck Medicine of USC

My Resources

Dr. George Yaghmour

Specialty:

My Resources
location-icon

Keck Medicine of USC

My Resources

Dr. Sungwon Rachel Kyung

Specialty: Internal Medicine, Hematology & Medical Oncology

My Resources
location-icon

Oncura Health (formerly Los Angeles Cancer Network)

My Resources

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider